_pptx-Photoroom.png)
Therapeutics
Platform
-
We engineer red blood cells to carry RNA payloads and small-molecule therapeutics to immune cells or targeted organs, allowing for controlled and localized treatment delivery.
-
This approach reduces off-target toxicity and enhances immune modulation—ideal for diseases such as lupus, sepsis, and certain cancers.
-
Our delivery vehicles are non-immunogenic, long-circulating, and designed for maximum bioavailability.
Diagnostics
Platform
-
Our diagnostic platform is designed for ultra-sensitive, same-day detection of disease signals using red blood cells.
-
Red blood cells capture RNA, protein, and pathogen signals from deep tissue and immune microenvironments, providing an earlier and more accurate disease readout than conventional plasma testing.
-
These tests are low-cost, scalable, and capable of detecting cancers, infections, and autoimmune signatures—all from a single drop of blood.
Building the Future of Cell-Based Medicine
Advantages of RBC Platforms
Immunologically silent
Non-toxic, naturally circulating cells
Early disease signal access from tissues
Compatible with both diagnostic and therapeutic use
